Glaucoma is linked with frailty and dementia in human studies, and with falls and visual impairment in older adults. A longitudinal human study associates glaucoma with faster retinal ganglion cell loss. Human cohorts also link advanced cardiovascular-kidney-metabolic syndrome and higher triglyceride-glucose indices with higher glaucoma risk.
287 findings in 198 papers from 2016 to 2026, 50 of them since April 2026
“Individuals who self-identified as having preexisting glaucoma (odds ratio [OR] = 3.749, 95% confidence interval [CI] = 1.741-8.074, p = 0.0001)”
↓downin mice2−70% eyes had no detectable glaucomatous neurodegeneration
2 studies
Nicotinamide protects against glaucoma in the DBA/2J mouse model of inherited glaucoma (~70% of eyes had no detectable glaucomatous neurodegeneration).
“At the lowest dose tested, nicotinamide robustly protected from glaucoma (~70% of eyes had no detectable glaucomatous neurodegeneration).”
Reviewin the DBA/2J mouse model of inherited glaucomaretinalowest dose tested
“Oral administration of the NAD+ precursor nicotinamide (vitamin B3), and/or gene therapy (driving expression of Nmnat1, a key NAD+-producing enzyme), was protective both prophylactically and as an intervention.”
Animalsglaucoma-prone mice; prophylactic and interventional administration, alone and/or with Nmnat1 gene therapyeye
Glaucoma is linked with worse gait speed in humans (-0.11 (-0.16 to -0.05) m/s).
“Individuals with glaucoma (-0.11 (-0.16 to -0.05) m/s), distance vision impairment (-0.02 (-0.03 to 0.00) m/s) or vision problem (-0.02 (-0.05 to 0.00) m/s) had decreased gait speed compared with the control group.”
Glaucoma is linked with worse gait speed in humans (glaucoma vs normal controls) (P < .05).
“When walking without an obstacle on a 6 m path, there were significant differences between the 2 groups in gait speed, cadence, gait cycle, and stance time (P < .05).”
Glaucoma is linked with lower ganglion cell soma density in humans within an arcuate defect (-31.6%/year).
“By contrast, one glaucoma patient showed a loss rate within an arcuate defect over 100× greater (-31.6%/year; corresponding GCL thinning rate of -13%/year)”
Glaucoma was not clearly linked with Parkinson's disease in humans (Glaucoma patients compared with sex- and age-matched controls) (Adjusted HR 1.145 (95% CI 0.975–1.345)).
“Glaucoma was not significantly associated with an increased risk of PD, with an adjusted HR of 1.145 (95% CI = 0.975-1.345).”
HumansGlaucoma patients compared with sex- and age-matched controls20-year follow-upn = 139,554
Clonal hematopoiesis of indeterminate potential was not clearly linked with glaucoma in humans (Free of the four eye diseases at baseline) (HR 1.08, 95% CI 0.99–1.17).
“No significant association was found with glaucoma (HR, 1.08; 95% CI, 0.99-1.17).”
HumansFree of the four eye diseases at baselineMedian follow-up of 13.1 years54.5% womensn = 436,469
Uric acid is linked with glaucoma in humans (mediating PM2.5 and component associations with glaucoma) (12% to 15%).
“Elevated serum UA levels played a mediated role in the association between PM2.5 mass and its five chemical components and glaucoma, with mediated proportions ranging from 12% to 15%.”
Humansmediating PM2.5 and component associations with glaucoma
Glaucoma is associated with Alzheimer's disease in humans (Compared with individuals without glaucoma) (POAG: aHR 1.23 (95% CI 1.08–1.40); NTG: 1.49 (1.19–1.85); PACG: 1.35 (1.19–1.52); unspecified glaucoma: 1.36 (1.23–1.50)).
“Irrespective of the type of glaucoma, individuals with glaucoma had a significantly higher risk of AD compared to those without glaucoma”
HumansCompared with individuals without glaucoman = 202,000
Glaucoma is linked with a lower risk of Alzheimer's disease in humans (genetically predicted all-cause glaucoma) (OR = 0.96, 95% CI: 0.93-0.99).
“The genetically predicted all-caused glaucoma was nominally associated with a decreased risk of Alzheimer's disease (OR = 0.96, 95% CI: 0.93-0.99, P = 0.013).”
Glaucoma is linked with a higher risk of Alzheimer's disease in humans (adjusted for sociodemographic factors and comorbidities) (adjusted HR 1.39 (95% CI 1.35-1.43)).
“Persons with glaucoma had increased risks for AD (adjusted HR, 1.39; 95% confidence interval [CI], 1.35-1.43), VaD (1.66; 1.61-1.72), and all-cause dementia (1.57; 1.54-1.59).”
Humansadjusted for sociodemographic factors and comorbidities
Diabetes mellitus is linked with a higher risk of glaucoma in humans (AOR 1.554, p < 0.01).
“the likelihood of cataract (AOR 1.495; p-value < 0.01) and glaucoma (AOR 1.554; p-value < 0.01) is significantly higher among older adults with diabetes than among their counterparts.”
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·
GLP-1 receptor agonists lower the risk of glaucoma in humans (diabetic and non-diabetic populations).
“Complementary clinical and real-world evidence shows a robust and reproducible reduction in glaucoma risk among GLP-1RA users across diabetic and non-diabetic populations.”
Fine particulate matter is associated with glaucoma in humans (National age-standardized prevalence rates worldwide in 2019) (Prevalence r = 0.65; DALY rate r = 0.62).
“National prevalence rates of VI and three major ocular diseases correlate significantly with PM2.5 exposure levels, worldwide.”
HumansNational age-standardized prevalence rates worldwide in 2019
Metformin is linked with a lower risk of glaucoma in humans (individuals of European ancestry with diabetes) (HR 0.81, 95% CI 0.67-0.97).
“Metformin use was associated with a 19% lower glaucoma risk (hazard ratio, 0.81; 95% confidence interval [CI], 0.67-0.97; P = 0.019) in individuals of European ancestry”
Humansindividuals of European ancestry with diabetes12.1 ± 2.8 yearsn = 24,206
Particulate matter is linked with a higher risk of glaucoma in humans (HR 1.31, 95% CI 1.18-1.45).
“The mixture of PM2.5 components were significantly and positively associated with glaucoma risk (hazard ratio [HR] = 1.31, 95% confidence interval [CI]: 1.18-1.45)”
Frailty is linked with a higher risk of glaucoma in humans (frail individuals vs nonfrail) (OR 1.83, 95% CI 1.05-3.19).
“higher frailty levels were significantly associated with glaucoma in frail individuals (odds ratio [OR] = 1.83, 95% confidence interval [CI] = 1.05-3.19, P = 0.036)”
Glaucoma predicts frailty in humans (longitudinal multivariable-adjusted) (OR 3.41 (95% CI 1.46 to 7.99)).
“In the longitudinal analysis, the multivariable-adjusted OR (95% CI) for incident frailty associated with glaucoma, distance vision impairment, near vision impairment and vision problem was 3.41 (1.46 to 7.99)”
Human studies associate glaucoma with frailty and biological age acceleration; a cohort links it to later Alzheimer's disease and vascular dementia. A longitudinal study reports more falls, while a comparison with glaucoma suspects reports no difference in falls or fractures. A mouse study links glaucoma to retinal cellular senescence.
In human studies, glaucoma is linked to retinal arteriosclerosis. Exposure to perfluorooctane sulfonic acid raises glaucoma risk, and perfluorodecanoic acid is associated with the disease in males.
An estimated 260,273 Ontarians aged 40–64 likely had undetected chronic eye conditions between 2005 and 2021, after routine eye examinations lost coverage.An estimated 260,273 Ontarians aged 40–64 likely had undetected chronic eye conditions between 2005 and 2021, after routine eye examinations lost coverage.